Wisr (ASX:WZR) share price pops following half-year results announcement

The Wisr share price hopped up today following the company's release of its first half FY21 results. Let's take a look at the highlights.

| More on:
Rising asx share price represented by woman with excited expression holding laptop

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The WISR Ltd (ASX: WZR) share price is up nearly 3% following release of the company's first half FY21 results today and is currently trading at 19 cents. The Wisr share price has fallen roughly 30% over the previous 12-month period.

Wisr is a consumer lending and fintech company. In today's results presentation, the company reiterated its aim to 'aggressively capture market share' in the consumer lending market. Wisr intends to 'reinvent' consumer lending by offering what it labels as fairer rates, a better loan experience, and financial literacy education.

Here are some highlights from Wisr's first half FY21 update.

Wisr's first half highlights

The company reported first half FY21 revenue of $10 million. This is a 354% increase compared to Wisr's  first half FY20 revenue of $2.2 million.

Overall cash earnings before interest, tax, depreciation and amortisation (EBITDA) for the period was $6.5 million. This was a 6% improvement compared to $6.9 million EBITDA reported for the prior corresponding period.

Operating expenses (Opex) increased by 59% during the first half of FY21. The company advised that this is in line with its management plan. Wisr pointed to the 59% Opex increase in relation to its 354% revenue increase, stating the two compare 'very favourably' and are in line with business deliverables.

Wisr reports that it currently has over $390.5 million in loans written to date. The company's loan originations rose 166% when comparing this half to the prior corresponding period. Loan originations for the period came in at $145.7 million.

Wisr CEO commentary

Commenting on the first half achievements, Wisr CEO Mr. Anthony Nantes said:

We have seen a substantial step-change in operating capability in the last six months. Our H1FY21 results delivered a significant 354% uplift in revenue while reducing overall Cash EBTDA loss by 6%, compared to this same period last financial year.

Investments in talent and technology, planned at the time of our January 2020 capital raise but deferred in response to COVID-19, have now been made. This means that increases in operating cost base will be more incremental in the medium term, resulting in significant operating leverage as revenue continues to grow strongly in-line with the growth of our loan book.

Motley Fool contributor Gretchen Kennedy has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »